NASDAQ · CGEN
Compugen financials
$2.35+0.86%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72.8M | $27.9M | $33.5M | $7.5M | $6.0M | $2.0M | $0.00 | $17.8M | $0.00 | $712.0K |
| Gross profit | $63.5M | $19.9M | $31.5M | $6.5M | $5.3M | $1.9M | $0.00 | $16.8M | $0.00 | $489.0K |
| Gross margin | 87.3% | 71.5% | 94.0% | 87.0% | 88.7% | 97.0% | — | 94.2% | — | 68.7% |
| Operating income | $31.3M | -$14.9M | -$13.0M | -$35.4M | -$35.1M | -$31.5M | -$28.9M | -$23.2M | -$37.4M | -$32.6M |
| Net income | $35.3M | -$14.2M | -$18.8M | -$33.7M | -$34.2M | -$29.7M | -$27.3M | -$22.6M | -$37.1M | -$31.5M |
| Net margin | 48.6% | −51.1% | −56.1% | −449.3% | −570.0% | −1484.9% | — | −127.0% | — | −4425.0% |
| Diluted EPS | $0.38 | $-0.16 | $-0.21 | $-0.39 | $-0.41 | $-0.37 | $-0.43 | $-0.41 | $-0.72 | $-0.62 |
| EBITDA | $31.8M | -$14.4M | -$12.5M | -$34.9M | -$34.6M | -$30.8M | -$27.9M | -$21.8M | -$35.8M | -$31.1M |
| Operating cash flow | $31.6M | $49.6M | -$35.9M | -$34.1M | -$22.7M | -$28.3M | -$27.9M | -$13.3M | -$30.7M | -$19.8M |
| Free cash flow | $31.3M | $49.5M | -$36.1M | -$34.6M | -$23.0M | -$28.5M | -$28.0M | -$13.4M | -$31.0M | -$22.4M |
| Diluted shares | 93.8M | 89.5M | 87.6M | 86.6M | 84.2M | 79.6M | 63.6M | 55.3M | 51.2M | 50.9M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $90.6M | $18.2M | $13.9M | $11.1M | $7.8M | $7.1M |
| Short-term investments | $55.0M | $85.0M | $36.8M | $72.3M | $109.2M | $116.6M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $156.6M | $115.0M | $121.3M | $94.2M | $132.2M | $138.3M |
| Total liabilities | $53.8M | $60.1M | $55.8M | $16.5M | $25.5M | $18.5M |
| Shareholders' equity | $102.7M | $54.9M | $65.6M | $77.7M | $106.7M | $119.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology